Načítá se...
Immune checkpoint inhibitors in cancer therapy
In recent years immune checkpoint inhibitors have garnered attention as being one of the most promising types of immunotherapy on the horizon. There has been particular focus on the immune checkpoint molecules, cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1) whic...
Uloženo v:
| Vydáno v: | J Biomed Res |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial Department of Journal of Biomedical Research
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163118/ https://ncbi.nlm.nih.gov/pubmed/28866656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.31.20160168 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|